ARCT·03969T109·US·equity·Healthcare - Biotechnology-13D/G
ARCT (ARCTURUS THERAPEUTICS HOLDIN) is held by 74 institutional investors as of Q1 2026. Largest holders: FEDERATED HERMES, INC. ($25.5M), ARK Investment Management LLC ($21.4M), BlackRock, Inc. ($20.2M). Net institutional sentiment: Mixed.
See how ARCT's score breaks down across 4 SEC sources
Showing 1-20 of 85
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer